Literature DB >> 3486312

Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease.

S Okuda, Y Oh, H Tsuruda, K Onoyama, S Fujimi, M Fujishima.   

Abstract

Serial changes in urine protein, blood chemistry, and histology of the kidney were investigated in rats for 28 weeks after injections of adriamycin (ADR). Massive proteinuria, hypoalbuminemia, and hyperlipidemia were observed at week 4 and throughout the experiment. Both BUN and serum creatinine began to increase at week 16 and reached the uremic level at week 28. Light microscopic study of the kidney demonstrated a normal appearance at week 4, vacuole formation in glomerular tuft at weeks 8 and 12, focal and segmental glomerular sclerosis at weeks 16 and 20, and extensive glomerular sclerosis with tubulointerstitial degenerations at weeks 24 and 28. Immunohistologically, IgM with a small amount of IgG and C3 appeared in the sclerosing glomeruli from week 16. Aggregated human IgG, injected intravenously at week 24, had accumulated mainly in the glomeruli. Electron microscopy revealed degenerative changes of glomerular epithelial cells with small vacuoles in the cytoplasm at week 4. Size of vacuoles increased at the later stage. In conclusion, ADR produced chronic, progressive glomerular changes in rats, which led to terminal renal failure. The segmental glomerular sclerosis and IgM-dominant glomerular deposition in these animals are similar to pathological characteristics of focal and segmental glomerular sclerosis seen clinically.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486312     DOI: 10.1038/ki.1986.28

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  50 in total

1.  Glomerular expression of apelin and its association with proteinuria.

Authors:  Yan Bo; Li-Ping Yuan
Journal:  Indian J Pediatr       Date:  2011-11-12       Impact factor: 1.967

2.  Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.

Authors:  G N Marinides; G C Groggel; A H Cohen; T Cook; R L Baranowski; C Westenfelder; W A Border
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

Review 4.  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio A Brito-Melo; Cayo Antônio Soares de Almeida; Lázaro Lopes Moreira; Cleiton Willian Cordeiro; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

5.  The efficiency of intraperitoneal high-dose immunoglobulin in experimental nephrotic syndrome.

Authors:  Seyhan Erisir; Halide Akbas; Mustafa Koyun; Sema Akman
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

6.  Valproic acid attenuates proteinuria and kidney injury.

Authors:  Katrien Van Beneden; Caroline Geers; Marina Pauwels; Inge Mannaerts; Dierik Verbeelen; Leo A van Grunsven; Christiane Van den Branden
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

7.  (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system.

Authors:  Renfei Luo; Kevin Yang; Fei Wang; Chuanming Xu; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-31

8.  The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varlakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

9.  Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.

Authors:  Shanshan Liu; Zhanjun Jia; Li Zhou; Ying Liu; Hong Ling; Shu-Feng Zhou; Aihua Zhang; Yaomin Du; Guangju Guan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-13

10.  Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Authors:  Yaojun Liang; Yu Jin; Yuning Li
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.